221 West Philadelphia Street
York, Pennsylvania 28277-3607
Dentsply Sirona (XRAY) rose 3.7% on speculation of a potential activist investor following a Morgan Stanley 13F filing.Morgan Stanley was the second biggest buyer of Dentsply (XRAY) in…
DENTSPLY SIRONA Inc. (NASDAQ:NASDAQ:XRAY) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Andrea Daley - VP, IR Simon Campion - Chief Executive Officer…
The following slide deck was published by DENTSPLY SIRONA Inc.
Satsuma Pharmaceuticals STSA -83% after reporting topline results from the STS101 SUMMIT Phase 3 efficacy trial.MorphoSys MOR -30% as Licensing Partner Roche faces another setback…
YORK (PENNSYLVANIA) (dpa-AFX) - Dentsply Sirona Inc.(XRAY), a maker of dental products and technologies, reported Monday that its third-quarter net loss was $1.08 billion, or $5.01 per share, comp…
Dentsply Sirona press release (XRAY): Q3 Non-GAAP EPS of $0.41 misses by $0.17.Revenue of $947M (-8.9% Y/Y) misses by $63M.Shares -5% PM.Updated FY22 outlook: organic sales decline…
CHARLOTTE, N.C., Nov. 14, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2022.
DENTSPLY SIRONA Inc. (XRAY)’s stock is trading at $31.64 at the moment marking a rise of 4.49% from the last session close. As of this writing, shares are priced at -46.10% less than their 52-week high of $58.70, and 19.49% over their 52-week low of $26.48. Based on the past 30-day period, the stock price […]
CHARLOTTE, N.C., Nov. 11, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) today announced its participation at upcoming conferences.
Dentsply Sirona (XRAY) is scheduled to announce Q3 earnings results on Friday, November 11th, after market close.The consensus EPS Estimate is $0.58 (-14.7% Y/Y) and the consensus…
Dentsply Sirona Inc. plans to restate its earnings and strengthen controls around financial reporting after wrapping up an internal investigation that delayed its quarterly filings for months and put the dental-products maker at risk of delisting.
YORK (PENNSYLVANIA) (dpa-AFX) - Dentsply Sirona Inc.(XRAY), a maker of dental products and technologies, said on Tuesday that it expects a slight decline in net sales for the third-quarter, reflec…
Announces Restatements of Third Quarter 2021 and Full Year 2021 Financials
As of Thursday, DENTSPLY SIRONA Inc.’s (NASDAQ:XRAY) stock closed at $29.42, down from $30.24 the previous day. While DENTSPLY SIRONA Inc. has underperformed by -2.71%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, XRAY fell by -48.80%, with highs and lows ranging from $59.46 to $28.12, […]
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) marked $29.15 per share on Thursday, down from a previous closing price of $29.78. While DENTSPLY SIRONA Inc. has underperformed by -2.12%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, XRAY fell by -50.11%, with highs and lows ranging from $59.78 to […]
Dentsply Sirona (XRAY) declared $0.125/share quarterly dividend, in line with previous.Payable Oct. 14; for shareholders of record Sept. 30; ex-div Sept. 29.See XRAY Dividend Scorecard…
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) price closed lower on Tuesday, September 27, dropping -1.15% below its previous close. A look at the daily price movement shows that the last close reads $29.69, with intraday deals fluctuated between $29.215 and $30.58. The company’s 5Y monthly beta was ticking 0.95 while its P/E ratio in the trailing 12-month … If You’re Not Bullish On DENTSPLY SIRONA Inc. (NASDAQ: XRAY) Now, You’ll Kick Yourself Later Read More »
Dentsply Sirona''s challenge this year has been ongoing regulatory firestorm since falling out of compliance by not releasing Q1 audited financial statements. Read more here on XRAY stock.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which m